Executive Vice President
Biotech and Specialty Services
Mr. Suchanek brings over 25 years of experience focused on patient services and specialty pharmacy operations. Prior to joining D2, Mr. Suchanek served as Vice President of Pharma Programs at CuraScript (specialty division of Express Scripts, Inc.) where he had responsibility for some of the organizations largest and most profitable business product/disease segments. During his time at CuraScript, Mr. Suchanek oversaw account management and program implementation with responsibility of over $1B in annual sales. In addition, Mr. Suchanek had responsibly for the organizations trade relations department, wholesale operations and distribution department including operational implementation of new biotech products and programs.
Prior to CuraScript Mr. Suchanek serviced as the VP of Pharmaceutical Services for Cardinal Health (CAH) focusing on Specialty Pharmacy/Distribution and Third Party Logistics. Mr. Suchanek also worked in roles of increasing responsibilities at Caremark, MIM Health Plan, Scrip Solutions/ Bioscrip (mail order and specialty pharmacy), CVS Procare and Allscripts Pharmaceuticals.
Additionally, Mr. Suchanek currently acts as an independent consultant for SRI Inc. (Stanford Research International), University of California-San Francisco and Yale University. David has participated in and moderated numerous advisory boards and has been a featured Keynote Speaker and National Panel participant on issues including Specialty Pharmacy, Specialty Distribution, Access Solutions, and Supply Chain/ GPO Channel Management.
Mr. Suchanek holds a degree in Pharmacy from Ohio Northern University College of Pharmacy. He has coordinated research projects on several biotechnology pipeline products at the University of Texas, M.D. Anderson Cancer Center. Mr. Suchanek is a Registered Pharmacist in Ohio and a Licensed Designated Representative in Florida.